Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,650 | 98 | 92.7% |
| Education | $130.57 | 3 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $330.76 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $216.36 | 11 | $0 (2018) |
| ABBVIE INC. | $165.11 | 8 | $0 (2024) |
| Allergan, Inc. | $118.01 | 8 | $0 (2020) |
| Novo Nordisk Inc | $106.23 | 6 | $0 (2024) |
| Exeltis, USA Inc. | $105.93 | 4 | $0 (2024) |
| CooperSurgical, Inc. | $91.37 | 5 | $0 (2024) |
| Mission Pharmacal Company | $80.02 | 5 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $67.56 | 4 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $54.45 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $262.57 | 13 | Novo Nordisk Inc ($74.46) |
| 2023 | $241.49 | 12 | Exeltis, USA Inc. ($57.90) |
| 2022 | $87.51 | 4 | PFIZER INC. ($40.54) |
| 2021 | $53.44 | 3 | Agile Therapeutics, Inc. ($19.86) |
| 2020 | $115.53 | 7 | PFIZER INC. ($33.49) |
| 2019 | $324.16 | 19 | PFIZER INC. ($58.81) |
| 2018 | $350.87 | 24 | PFIZER INC. ($66.94) |
| 2017 | $344.75 | 19 | Astellas Pharma US Inc ($195.25) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 11/12/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/23/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: WOMENS HEALTH | ||||||
| 09/24/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: WOMENS HEALTH | ||||||
| 08/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Obesity | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: HORMONE THERAPY | ||||||
| 06/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Obesity | ||||||
| 06/05/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: VACCINES | ||||||
| 05/11/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: WOMENS HEALTH | ||||||
| 04/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Obesity | ||||||
| 03/06/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Endocrinology | ||||||
| 02/12/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $28.34 | General |
| 02/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Obesity | ||||||
| 12/20/2023 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: VACCINES | ||||||
| 12/06/2023 | PFIZER INC. | MYFEMBREE (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 11/15/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: VACCINE | ||||||
| 11/01/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: Oral Contraceptive | ||||||
| 10/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Obesity | ||||||
| 10/13/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: WOMENS HEALTH | ||||||
| 10/06/2023 | PFIZER INC. | MYFEMBREE (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 10/04/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Obesity | ||||||
| 08/15/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: WOMENS HEALTH | ||||||
| 08/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Womens Health | ||||||
| 07/06/2023 | Smith+Nephew, Inc. | PICO (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 01/30/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Oral Contraceptive | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 16 | $788.00 | $595.52 |
| 2022 | 1 | 24 | 24 | $1,008 | $930.66 |
| 2021 | 3 | 69 | 78 | $5,478 | $3,843 |
| 2020 | 3 | 55 | 60 | $3,870 | $2,508 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 16 | 16 | $788.00 | $595.52 | 75.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 24 | 24 | $1,008 | $930.66 | 92.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 30 | $3,390 | $1,925 | 56.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 36 | 36 | $1,512 | $1,402 | 92.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 12 | 12 | $576.00 | $516.36 | 89.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 25 | 25 | $1,050 | $980.72 | 93.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 20 | $2,100 | $889.40 | 42.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 15 | 15 | $720.00 | $637.45 | 88.5% |
About Katherine Lammers
Katherine Lammers is a Obstetrics & Gynecology healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760481675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Katherine Lammers has received a total of $1,780 in payments from pharmaceutical and medical device companies, with $262.57 received in 2024. These payments were reported across 101 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,650).
As a Medicare-enrolled provider, Lammers has provided services to 164 Medicare beneficiaries, totaling 178 services with total Medicare billing of $7,877. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Rochester, NY
- Active Since 07/21/2005
- Last Updated 01/24/2019
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1760481675
Products in Payments
- PREMARIN (Drug) $190.26
- LO LOESTRIN FE (Drug) $118.01
- Myrbetriq (Drug) $110.25
- Wegovy (Drug) $106.23
- SLYND (Drug) $105.93
- Orilissa (Drug) $75.58
- PVC (Drug) $67.32
- MYFEMBREE (Drug) $61.47
- Paragard (Device) $58.26
- CERVIDIL (Drug) $54.45
- Uribel (Drug) $53.06
- SOLOSEC (Drug) $52.36
- ORILISSA (Drug) $48.72
- VYLEESI (Drug) $45.57
- LILETTA (Drug) $40.81
- IMVEXXY (Drug) $39.66
- Kyleena (Drug) $38.59
- ABRYSVO (Biological) $35.74
- MD cobas Instruments and Reagents (Device) $34.35
- Mirena (Drug) $28.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Rochester
Jani Jensen, Md, MD
Obstetrics & Gynecology — Payments: $60,957
Elizabeth Stewart, Md, MD
Obstetrics & Gynecology — Payments: $26,069
Dale Ferguson, Md, MD
Obstetrics & Gynecology — Payments: $22,638
Franziska Haydanek, D.o, D.O
Obstetrics & Gynecology — Payments: $20,510
William Cliby, M.d, M.D
Obstetrics & Gynecology — Payments: $14,858
Jorge Carrillo, Md, MD
Obstetrics & Gynecology — Payments: $10,045